4/9/2019 9:57 AM
Near the bottom of the Nasdaq this morning is Zogenix, Inc. (NASDAQ:ZGNX), down 24.8% to trade at $38.97, after the Food and Drug Administration (FDA) refused to review the drugmaker's marketing appl...
3/18/2019 10:22 AM
Two biotech stocks have nearly doubled in value today, and sit near the top of the Nasdaq. First up, PhaseBio Pharmaceuticals Inc (NASDAQ:PHAS) is up 75.3% to trade at $6.52, and earlier nabbed a rec...